These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 19447866)
21. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Schoeffner DJ; Matheny SL; Akahane T; Factor V; Berry A; Merlino G; Thorgeirsson UP Lab Invest; 2005 May; 85(5):608-23. PubMed ID: 15765121 [TBL] [Abstract][Full Text] [Related]
22. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
23. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N Am J Pathol; 2007 Mar; 170(3):1086-99. PubMed ID: 17322391 [TBL] [Abstract][Full Text] [Related]
24. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315 [TBL] [Abstract][Full Text] [Related]
26. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107 [TBL] [Abstract][Full Text] [Related]
27. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629 [TBL] [Abstract][Full Text] [Related]
28. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828 [TBL] [Abstract][Full Text] [Related]
30. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors. Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830 [TBL] [Abstract][Full Text] [Related]
31. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. Lam JB; Chow KH; Xu A; Lam KS; Liu J; Wong NS; Moon RT; Shepherd PR; Cooper GJ; Wang Y PLoS One; 2009; 4(3):e4968. PubMed ID: 19319191 [TBL] [Abstract][Full Text] [Related]
32. Adiponectin is a negative regulator of antigen-activated T cells. Wilk S; Scheibenbogen C; Bauer S; Jenke A; Rother M; Guerreiro M; Kudernatsch R; Goerner N; Poller W; Elligsen-Merkel D; Utku N; Magrane J; Volk HD; Skurk C Eur J Immunol; 2011 Aug; 41(8):2323-32. PubMed ID: 21538348 [TBL] [Abstract][Full Text] [Related]
33. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074 [TBL] [Abstract][Full Text] [Related]
34. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
35. Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Dwenger A; Rosenthal F; Machein M; Waller C; Spyridonidis A Stem Cells; 2004; 22(1):86-92. PubMed ID: 14688394 [TBL] [Abstract][Full Text] [Related]
36. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Howe LR; Chang SH; Tolle KC; Dillon R; Young LJ; Cardiff RD; Newman RA; Yang P; Thaler HT; Muller WJ; Hudis C; Brown AM; Hla T; Subbaramaiah K; Dannenberg AJ Cancer Res; 2005 Nov; 65(21):10113-9. PubMed ID: 16267038 [TBL] [Abstract][Full Text] [Related]
37. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874 [TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM; Welsh J Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467 [TBL] [Abstract][Full Text] [Related]
39. RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus. Sarkar NH; Golovkina T; Uz-Zaman T J Virol; 2004 Jan; 78(2):1055-62. PubMed ID: 14694140 [TBL] [Abstract][Full Text] [Related]
40. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]